These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12753944)

  • 1. Vaginal dryness assessment in postmenopausal women using pH test strip.
    Carranza-Lira S; Fragoso-Díaz N; MacGregor-Gooch AL; Garduño-Hernández MP; Ríos-Calderón K; Aparicio H
    Maturitas; 2003 May; 45(1):55-8. PubMed ID: 12753944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in vaginal dryness according to hormone therapy schedule using pH test strip in two groups of postmenopausal women.
    Carranza-Lira S; MacGregor-Gooch AL
    Int J Fertil Womens Med; 2004; 49(2):88-90. PubMed ID: 15188835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in maturation index and vaginal dryness after treatment with topical conjugated estrogens in low and conventional dose].
    Carranza-Lira S; de Jesús Cabrera-López T; Estrada-Moscoso I; Aguado-Pérez RA
    Rev Med Inst Mex Seguro Soc; 2012; 50(3):315-8. PubMed ID: 23182262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modification of C3 and C4 levels after the administration of conjugated estrogens plus medroxiprogesterone or raloxifene in postmenopausal women].
    Carranza Lira S; MacGregor Gooch AL; Olivares A; González Legorreta SL; Saldívar N; Martínez Chéquer JC
    Ginecol Obstet Mex; 2005 Oct; 73(10):521-4. PubMed ID: 16583831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular changes after hormone replacement therapy in postmenopausal women. A preliminary report].
    Carranza Lira S; Jiménez AM; Olhovich I
    Ginecol Obstet Mex; 2005 Apr; 73(4):194-7. PubMed ID: 21966755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women.
    Suwanvesh N; Manonai J; Sophonsritsuk A; Cherdshewasart W
    Menopause; 2017 Feb; 24(2):210-215. PubMed ID: 27749740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in maturation index and vaginal dryness in postmenopausal women who use or not calcitriol].
    Carranza-Lira S; Amador-Pérez C; Macgregor-Gooch AL; Estrada-Moscoso I
    Rev Med Inst Mex Seguro Soc; 2012; 50(5):537-40. PubMed ID: 23282268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy.
    Galhardo CL; Soares JM; Simões RS; Haidar MA; Rodrigues de Lima G; Baracat EC
    Clin Exp Obstet Gynecol; 2006; 33(2):85-9. PubMed ID: 16903243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
    Portman D; Palacios S; Nappi RE; Mueck AO
    Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women.
    Long CY; Liu CM; Hsu SC; Wu CH; Wang CL; Tsai EM
    Menopause; 2006; 13(5):737-43. PubMed ID: 16946685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
    Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
    Utian WH; Shoupe D; Bachmann G; Pinkerton JV; Pickar JH
    Fertil Steril; 2001 Jun; 75(6):1065-79. PubMed ID: 11384629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
    Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
    Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
    Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.